Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes

Endocrinology

Volumn 141, Issue 12, 2000, Pages 4419-4427

  Raposinho, Paula D ^a   Castillo, Einar ^b   D'Alleves, Violaine ^a   Broqua, Pierre ^a   Pralong, François P ^b   Aubert, Michel L ^a,c  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b University of Lausanne Medical Center   (Switzerland)

^c Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; LEPTIN; MELANOCORTIN 4 RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; GENE EXPRESSION; GROWTH HORMONE DEFICIENCY; HYPERPHAGIA; HYPOGONADISM; MALE; NONHUMAN; OBESITY; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE; RAT; RECEPTOR BLOCKING; SATIETY; SEMINAL VESICLE; SIGNAL TRANSDUCTION;

EID: 0034527518     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.12.7842     Document Type: Article

References (67)

1. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight
2. The central melanocortin system and energy homeostasis
3. Obesity and the hypothalamus: Novel peptides for new pathways
4. ACTH-(1-24) and α-MSH antagonize feeding behavior stimulated by κ opiate agonists
5. The cloning of a family of genes that encode the melanocortin receptors
6. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor
7. Hypothalamic expression of ART, a novel gene related to agouti, is upregulated in obese and diabetic mutant mice
8. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
9. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur
10. vy/a) mice
11. Overexpression of AGRT leads to obesity in transgenic mice
12. Targeted disruption of the melanocortin-4 receptor results in obesity in mice
13. Role of the CNS melanocortin system in the response to overfeeding
14. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
15. Melanocortin mediated inhibition of feeding behavior in rats
16. Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats
17. Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): Evaluation in vitro and in vivo
18. Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats
19. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide
20. Neuropeptide Y injected in the paraventricular nucleus: Powerful stimulant of feeding behavior
21. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity
22. Effect of neuropeptide Y on ingestive behaviors in the rat
23. Neuropeptidergic regulation of feeding behavior: Neuropeptide Y
24. Brain neuropeptide Y: An integrator of endocrine, metabolic and behavioural processes
25. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food
26. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-diabetic rats
27. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome
28. Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y
29. Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists
30. Mandatory neuropeptide-steroid signalling for the preovulatory luteinizing hormone-releasing hormone discharge
31. Norepinephrine-like effects of neuropeptide Y in the rat
32. Neuropeptide Y suppresses pulsatile secretion of luteinizing hormone in ovariectomized rats: Possible site of action
33. Bimodal effects of neuropeptide Y on hypothalamic release of gonadotropin-releasing hormone in conscious rabbits
34. Third-ventricular infusion of neuropeptide Y suppresses luteinizing hormone secretion in ovariectomized rhesus monkeys
35. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and somatotropic axis in the intact adult female rats
36. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in adult male rats
37. Chronic administration of neuropeptide Y into the lateral ventricle starting at 30 days of life delays sexual maturation in the female rat
38. Evidence that the inhibition of LH secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype
39. Positional cloning of the mouse obese gene and its human homologue
40. The role of neuropeptide Y in the antiobesity action of the obese gene product
41. Metabolic control of sexual function and growth: Role of neuropeptide Y and leptin
42. Central nervous system mediation of the biologic activity of obese protein (leptin): Potential role in states of altered energy balance
43. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin
44. Leptin treatment rescue the sterility of genetically obese ob/ob males
45. Evidence for a central mechanism of obesity in the Zucker rat: Role of neuropeptide Y and leptin
46. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity
47. Radioimmunoassay for insulin-like growth factor-I: Solutions to some potential problems and pitfalls
48. Growth hormone (GH) deprivation induced by passive immunization against rat GH-releasing factor does not disturb the course of sexual maturation and fertility in the female rat
49. Differential activation of the pituitary-adrenocortical axis after stress in the rat: Use of two genetically selected lines (Roman low- and high-avoidance rats) as a model
50. Pituitary receptor sites for gonadotropin-releasing hormone: Effect of castration and substitutive therapy with sex steroids in the male rat
51. Evidence for a leptin-neuropeptide Y axis for the regulation of growth hormone secretion in the rat
52. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin
53. Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands
54. Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction
55. Growth of inbred yellow (Ay) and non-yellow (aa) mice in parabiosis
56. In Zucker diabetic fatty rats plasma leptin levels are correlated with plasma insulin levels rather than with body weight
57. STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats
58. Leptin increases hypothalamic proopiomelanocortin (POMC) mRNA expression in the rostral arcuate nucleus
59. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus
60. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice
61. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin
62. Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight
63. Melanocortin receptors in leptin effects
64. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation
65. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats
66. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides
67. Decreased central and peripheral catecholaminergic activation in obese Zucker rats